Charlotte, NC, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Pulmera, a medical technology company advancing intraoperative imaging, today announced Jared Slibeck has been named Chief Commercial Officer, effective September 1, 2026. Slibeck will lead Pulmera’s commercial strategy and market development as the company accelerates the global advancement of the category-defining CBeam™ 3D Imaging Platform, its FDA 510(k)-cleared system that turns standard 2D C-arms that hospitals already own into true 3D DICOM intraoperative imaging systems in seconds.
Slibeck joins Pulmera after more than twenty years at Stryker. He achieved the highest lifetime sales in the history of Stryker’s Enabling Technologies division and delivered twenty quotas across his Stryker career, at times carrying more than one quota in a single year. He assumed early P&L responsibility as a regional manager and built commercial strategies across neurosurgery, spine, ENT, orthopedics, oncology, and trauma, working with surgeons and health systems across North America and Western Europe.
“Jared has operated at the center of surgical enabling technology for his entire career, and he understands how a new category becomes a standard,” said Kevin McGann, Chief Executive Officer of Pulmera. “The fact that a leader of his caliber is choosing to lead our commercial effort speaks volumes about the opportunity he sees here. For decades, true 3D visualization in surgery has been a privilege available only to those who could afford it. Jared has spent his career bringing advanced technology into the operating room. Now, he has the opportunity to help remove that barrier and make this capability accessible to every surgeon.”
“I spent more than two decades seeing firsthand how access to advanced 3D imaging was limited by cost,” added Slibeck. “Some of the best surgeons and hospitals are still making three-dimensional decisions from two-dimensional images. The clinical need is there, but the technology requires significant capital investment. When I saw true DICOM 3D imaging generated in seconds from a standard C-arm the hospital already owned, I immediately recognized the significance of the CBeam technology. This represents a new category of C-Arm Native 3D imaging with the potential to make advanced visualization accessible to far more surgeons and operating rooms. That’s the kind of opportunity I want to be part of.”
Slibeck’s appointment comes as the CBeam platform expands its clinical use following FDA clearance earlier this year. Since the company completed its first clinical cases in August 2026, adoption has accelerated quickly: Dr. Matthew McGirt of Carolina Neurosurgery and Spine Associates has performed more than 21 navigated spine cases at Atrium Health Mercy, and Dr. Kent Ellington at OrthoCarolina has performed more than six foot and ankle cases.
CBeam is designed to transform conventional 2D surgical C-arms into intraoperative 3D imaging systems, helping surgical teams visualize complex anatomy during procedures while enabling hospitals to expand access using imaging infrastructure they already own. The platform uses a position-sensor-based system that attaches to widely installed surgical C-arms. During a brief rotational scan, CBeam captures a series of X-ray images and reconstructs them into a 3D dataset, enabling intraoperative visualization to support clinical evaluation, navigation, and surgical decision-making.
About Pulmera, Inc.
Based in Charlotte, North Carolina, Pulmera, Inc. is a medical technology company focused on advancing intraoperative imaging through its flagship platform, CBeam. The company has developed and is commercializing scalable imaging technology that transforms conventional surgical C-arm systems into intraoperative 3D imaging tools, supporting broader access to advanced surgical visualization and clinical decision-making. For more information, visit www.pulmera.com or www.cbeam.com.
Attachment
Kevin McGann Pulmera (630) 240-3131 kevin.mcgann@pulmera.com